Kai Pharmaceuticals
Clinical trials sponsored by Kai Pharmaceuticals, explained in plain language.
-
New drug KAI-1678 tested for shingles nerve pain relief
Symptom relief CompletedThis Phase 2 trial tested whether a single dose of KAI-1678 can reduce pain in people with postherpetic neuralgia, a type of nerve pain that lingers after shingles. 23 adults with stable pain levels received either KAI-1678, a placebo, or lidocaine. The main goal was to see if pa…
Phase: PHASE2 • Sponsor: KAI Pharmaceuticals • Aim: Symptom relief
Last updated Jun 26, 2026 13:06 UTC
-
New drug KAI-1678 tested for spinal cord injury pain
Symptom relief CompletedThis Phase 2 trial tested whether KAI-1678, given as a single injection under the skin, can reduce pain in people with spinal cord injury. Only 5 adults with long-term spinal cord injury and chronic pain took part. The study compared KAI-1678 to a placebo to see if it improved pa…
Phase: PHASE2 • Sponsor: KAI Pharmaceuticals • Aim: Symptom relief
Last updated Jun 26, 2026 12:48 UTC